|
Indications & Usage Section Bupropion Hydrochloride Extended-Release Tablets, Usp (Sr)are Indicated For The Treatment Of Major Depressive Disorder (Mdd), As Defined By The Diagnostic And Statistical Manual (Dsm). The Efficacy Of Bupropion In The Treatment Of A Major Depressive Episode Was Established In Two 4-Week Controlled Inpatient Trials And One 6-Week Controlled Outpatient Trial Of Adult Subjects With Mdd [See Clinical Studies ( 14 )]. The Efficacy Of Bupropion Hydrochloride Extended-Release Tablets, Usp (Sr) In Maintaining An Antidepressant Response For Up To 44 Weeks Following 8 Weeks Of Acute Treatment Was Demonstrated In A Placebo-Controlled Trial [See Clinical Studies ( 14 )].
|